Evidence map›Paper›PMID 39912712›Full record

ArticleMicrobiology spectrum2025

Reply to Mitsuboshi, "Enhancing result reliability by addressing potential confounding factors".

Tomoyuki Ishigo, Kazuaki Matsumoto, Hiroaki Yoshida, Hiroaki Tanaka, Yuta Ibe, Satoshi Fujii, Masahide Fukudo, Hisato Fujihara, Fumihiro Yamaguchi, Fumiya Ebihara and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Tomoyuki IshigoDepartment of Pharmacy, Sapporo Medical University Hospital, Sapporo, Japan.ORCID 0000-0002-2689-5338
Kazuaki MatsumotoDivision of Pharmacodynamics, Faculty of Pharmacy, Keio University, Tokyo, Japan.ORCID 0000-0002-5462-1684
Hiroaki YoshidaDepartment of Pharmacy, Kyorin University Hospital, Mitaka, Japan.
Hiroaki TanakaDepartment of Pharmacy, Kyorin University Hospital, Mitaka, Japan.
Yuta IbeDepartment of Pharmacy, Sapporo Medical University Hospital, Sapporo, Japan.
Satoshi FujiiDepartment of Pharmacy, Sapporo Medical University Hospital, Sapporo, Japan.ORCID 0000-0002-0353-7933
Masahide FukudoDepartment of Pharmacy, Sapporo Medical University Hospital, Sapporo, Japan.
Hisato FujiharaDepartment of Pharmacy, Showa University Fujigaoka Hospital, Yokohama, Japan.
Fumihiro YamaguchiDepartment of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Fumiya EbiharaDepartment of Pharmacy, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Takumi MaruyamaDepartment of Pharmacy, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Yukihiro HamadaDepartment of Pharmacy, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Masaru SamuraDivision of Pharmacodynamics, Faculty of Pharmacy, Keio University, Tokyo, Japan.ORCID 0000-0002-8637-1237
Fumio NagumoDepartment of Pharmacy, Yokohama General Hospital, Yokohama, Japan.
Toshiaki KomatsuDepartment of Pharmacy, Kitasato University Hospital, Sagamihara, Japan.ORCID 0000-0003-4196-0756
Atsushi TomizawaDepartment of Pharmacy, Kitasato University Hospital, Sagamihara, Japan.
Akitoshi TakumaDepartment of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan.
Hiroaki ChibaDepartment of Pharmacy, Tohoku Kosai Hospital, Sendai, Japan.
Yoshifumi NishiCenter for Pharmacist Education, School of Pharmacy, Nihon University, Funabashi, Japan.
Yuki EnokiDivision of Pharmacodynamics, Faculty of Pharmacy, Keio University, Tokyo, Japan.ORCID 0000-0002-5934-0670
Kazuaki TaguchiDivision of Pharmacodynamics, Faculty of Pharmacy, Keio University, Tokyo, Japan.
Ayako SuzukiDepartment of Pharmacy, Showa University Fujigaoka Hospital, Yokohama, Japan.

Funding

Dainippon Sumitomo Pharma (Dainippon Sumitomo Pharma Co., Ltd.)Meiji Seika PharmaShionogi (Shionogi & Co. Ltd.)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

area under the concentration–time curvenephrotoxicitytherapeutic drug monitoringvancomycin

Identifiers

PMID39912712
PMCPMC11878002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.